Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-20
TNBC
Basal A
Selumetinib
MEK
MAPK
11854.155
uM
inf
inf
0.9135 0.9135 0.0000 0.0714
0.3056
1.3396
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9146.122
uM
inf
inf
0.9694 0.9694 0.0000 -0.0404
-1.9847
1.3408
BT-474
HER2amp
Luminal
Nilotinib
ABL
nRTK
12056.145
uM
inf
inf
0.9538 0.9538 0.0000 0.0958
0.3538
0.8365
600MPE
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
12224.135
uM
inf
inf
0.7869 0.7869 0.0000 0.0993
0.1270
1.0314
600MPE
HR+
Luminal
Cetuximab
EGFR
ErbB
7791.018
uM
inf
inf
0.8577 0.8577 0.0000 -0.0332
0.4860
0.8558
BT-474
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
12056.154
uM
inf
inf
0.7002 0.7002 0.0000 0.2152
-0.1183
0.9136
BT-483
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
11855.154
uM
inf
inf
0.6553 0.6553 0.0000 0.2233
0.0021
0.6282
600MPE
HR+
Luminal
2-deoxyglucose
13091.177
uM
inf
inf
0.9504 0.9504 0.0000 0.3143
0.0580
0.7004
BT-20
TNBC
Basal A
Dichloroacetate
PDK
PDK
13579.176
uM
inf
inf
0.8837 0.8837 0.0000 -0.0031
0.4777
0.7690
AU565
HER2amp
Luminal
GM6001
MMP
MMP
5900.096
uM
inf
inf
0.9215 0.9215 0.0000 0.0442
0.2561
2.7795
600MPE
HR+
Luminal
JNK-IN-5A
JNK
JNK
12224.144
uM
inf
inf
0.9302 0.9302 0.0000 0.0839
0.0000
1.0210
600MPE
HR+
Luminal
AG1024
IGF1R
RTK
5898.066
uM
inf
inf
1.0423 1.0423 0.0000 0.0282
0.0610
0.6097
600MPE
HR+
Luminal
AG1024
IGF1R
RTK
5899.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0165
0.0780
0.7056
BT-474
HER2amp
Luminal
GSK461364
PLK1
PLK
9158.001
uM
inf
inf
-0.9965 -0.9965 0.0000 0.3194
0.2618
0.6988
600MPE
HR+
Luminal
Dichloroacetate
PDK
PDK
13091.176
uM
inf
inf
0.9717 0.9717 0.0000 0.0439
-0.10
0.8746
BT-20
TNBC
Basal A
Trastuzumab
HER2
ErbB
5903.102
uM
inf
inf
1.0500 1.0500 0.0000 -0.0171
-0.1575
1.2557
600MPE
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
12224.072
uM
inf
inf
0.8349 0.8349 0.0000 0.1299
-0.0188
1.0105
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
BT-20
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
5904.098
uM
inf
inf
0.8819 0.8819 0.0000 0.0368
0.3491
1.3264
600MPE
HR+
Luminal
ICRF-193
TOP2
TOP
12224.157
uM
inf
inf
0.6710 0.6710 0.0000 0.1152
0.3373
1.0737
600MPE
HR+
Luminal
GSK923295
CENPE
Kinesin
9118.001
uM
inf
inf
0.5960 0.5960 0.0000 0.1146
0.4985
1.0946
600MPE
HR+
Luminal
GW-5074
CRAF
MAPK
5898.088
uM
inf
inf
0.8157 0.8157 0.0000 0.0414
-0.0040
0.6095
BT-474
HER2amp
Luminal
PD184352
MEK
MAPK
12056.155
uM
inf
inf
0.5832 0.5832 0.0000 0.2074
0.1106
0.8251
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7811.018
uM
inf
inf
0.6946 0.6946 0.0000 0.1308
-0.0060
0.4694
HCC1187
TNBC
Basal A
Celecoxib
COX2
COX
10518.136
uM
inf
inf
0.9091 0.9091 0.0000 0.0220
0.1805
1.2490